Julia G. Butchko - 11 Sep 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role
Chief Dev. & Tech. Officer
Signature
/s/ Julia G. Butchko
Issuer symbol
IMVT
Transactions as of
11 Sep 2021
Transactions value $
$0
Form type
4
Filing time
14 Sep 2021, 16:02:07 UTC
Previous filing
04 Aug 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMVT Stock Option (right to buy) Award $0 +320K $0.00 320K 11 Sep 2021 Common Stock 320K $8.62 Direct F1
transaction IMVT Stock Option (right to buy) Disposed to Issuer $0 -320K -100% $0.00* 0 11 Sep 2021 Common Stock 320K $19.01 Direct F1
transaction IMVT Stock Option (right to buy) Award $0 +191K $0.00 191K 11 Sep 2021 Common Stock 191K $8.62 Direct F2
transaction IMVT Stock Option (right to buy) Disposed to Issuer $0 -191K -100% $0.00* 0 11 Sep 2021 Common Stock 191K $17.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the options vested on May 15, 2021, and the remainder vested or vests in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.
F2 Shares underlying the options vest over four years, with 25% of the shares underlying the options vesting on March 19, 2022 and the remainder of the shares underlying the options vesting in 36 equal monthly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer as of each such date.